Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
07/2012
07/18/2012CN102584976A Human serum amyloid A1 and preparation method and application thereof
07/18/2012CN102584974A Acipenser sinensis antibacterial peptide and preparation method and application thereof
07/18/2012CN102584954A Protein for treating blood vessel hyperplasia of eyes
07/18/2012CN102584949A Pc-C polypeptide inhibiting aspergillus fumigatus from adhering to cornea
07/18/2012CN102584946A Cam binding peptide and application thereof
07/18/2012CN102584940A Peptidic compounds
07/18/2012CN102584939A Peptidic compounds
07/18/2012CN102584937A Crystal forms of (3r)-1-(2-methylalanyl-d-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide
07/18/2012CN102580232A Silk fibroin micro-needle system, silk fibroin nanometer particle and preparation method thereof
07/18/2012CN102580114A Novel applications of novel potential anti-cancer gene CMTM7 and encoding protein thereof
07/18/2012CN102580092A Regulation of ferroportin and application thereof
07/18/2012CN102580072A Combination neisserial compositions
07/18/2012CN102580069A Eye-drop vaccine containing copolymer 1 for therapeutic immunization
07/18/2012CN102580068A Compound perfusate for treating mammitis of dairy cattle and preparation method thereof
07/18/2012CN102580067A Combination therapy for treating protein deficiency disorders
07/18/2012CN102580066A Combination therapy for treating protein deficiency disorders
07/18/2012CN102580065A Ornithogalum caudatum saponin OSW-1 oral anticancer preparation and preparation method thereof
07/18/2012CN102580064A Medicinal application of superoxide dismutase (SOD) to treatment of rhinitis
07/18/2012CN102580063A Preparation method of xanthine oxidase inhibitor
07/18/2012CN102580062A Dry heat treatment stabilizing agent for human coagulation factor VIII and vWF (von willebrand factor) compound or human coagulation factor VIII preparation
07/18/2012CN102580061A Intranasal insulin preparation and preparation method thereof
07/18/2012CN102580060A Medicine composition for curing diabetes mellitus and complications of diabetes mellitus
07/18/2012CN102580059A Application of thymosin extrasin alpha in preparing medicine for preventing and curing cancer of liver
07/18/2012CN102580058A Therapeutic agent for blood-related disease containing epo derivative
07/18/2012CN102580057A Medicine composition containing ergometrine and oxytocin analogue and preparation method
07/18/2012CN102580056A Controlled-release injection containing antidiuresis components and preparation method thereof
07/18/2012CN102580055A Troxerutin-cerebroprotein hydrolysate dripping pill and preparation method thereof
07/18/2012CN102580054A Female scalp soothing hair-care shampoo and preparation method thereof
07/18/2012CN102579347A Thymalfasin liposome preparation for injecting
07/18/2012CN102579313A External liquid preparation capable of preventing secondary chromatosis from happening after skin trauma operations
07/18/2012CN102212124B Scylla paramamosain anti-lipopolysaccharide factor, and preparation method and application thereof
07/18/2012CN102021160B Snake venom serine protease and coding gene and application thereof
07/18/2012CN102008436B Nocathiacin antibiotic medicament composition containing emulsifying agent
07/18/2012CN101987195B Reduced glutathione medicine absorbed through oral mucosa
07/18/2012CN101884781B Pharmaceutical composition for preventing or treating rejection reaction of organ or tissue transplantation or graft versus host reaction of bone marrow transplantation
07/18/2012CN101875693B Albumin variant having anti-angiogenesis activity and preparation method thereof
07/18/2012CN101863958B Induction of the mitochondrial permeability transition
07/18/2012CN101829125B Compound combined formulation for preventing and treating osteoarthrosis and preparation method thereof
07/18/2012CN101732696B Method for preparing composition of peptide, calcium and magnesium
07/18/2012CN101711862B Medicine target spot relevant to inflammatory diseases and application thereof
07/18/2012CN101693105B Application of IL-4-like recombinant protein of fishes
07/18/2012CN101671396B Vascular endothelial growth factor specifically combined with collagen and application thereof
07/18/2012CN101646436B Use of antagonists of oxytocin and/or vasopressin in assisted reproductive technology
07/18/2012CN101613394B Method for preparing mouse nerve growth factor and method for preparing mouse nerve growth factor for injection
07/18/2012CN101611144B Recombinant viral proteins and particles
07/18/2012CN101501062B Novel biologically active peptides and their new uses
07/18/2012CN101440124B Methods for preventing mitochondrial permeability transition
07/18/2012CN101217965B Glucose uptake modulator and method for treating diabetes or diabetic complications
07/18/2012CN101189252B Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof
07/18/2012CN101188999B A pharmaceutical delivery system for delivering active component dispersed in dispersion medium
07/18/2012CN101139590B Hybrid expression of neisserial proteins
07/18/2012CN101137700B Microparticle and pharmaceutical composition
07/18/2012CN101137391B Uses of recombinant super-compound interferon
07/18/2012CN101121935B Chlamys farreri serine protease inhibitor CfKZSPI gene and its coding protein and application
07/18/2012CN101031339B Lysis/resealing process and device for incorporating an active ingredient in erythrocytes
07/17/2012US8222479 Recombinant organism and protein produced by the recombinant organism
07/17/2012US8222394 MicroRNA molecules
07/17/2012US8222392 Kit for detection of telomerase reverse transcriptase nucleic acids
07/17/2012US8222384 Modified and stabilized GDF propeptides and uses thereof
07/17/2012US8222371 vWFA and/or ANT—IG domain containing proteins
07/17/2012US8222368 Cosmetic and/or pharmaceutical composition comprising as an active principle at least one peptide and use of this peptide
07/17/2012US8222298 Methods of correcting imbalance between bone resorption and bone formation and kits and compositions therefor
07/17/2012US8222217 Unacylated ghrelin as therapeutic agent in the treatment of metabolic disorders
07/17/2012US8222216 Mesenchymal cell proliferation promoter and skeletal system biomaterial
07/17/2012US8222215 Methods for the use of inhibitors of antigen presentation by MHC class II molecules
07/17/2012US8222214 Vaccine for the prevention of breast cancer relapse
07/17/2012US8222213 Activated amino- and carboxy-terminal forms of Notch
07/17/2012US8222212 Prolactin induced increase in neural stem cell numbers
07/17/2012US8222211 Preimplantation factor; enhance endometrial receptivity, blocking activated but not basal immunity, inhibiting cell proliferation and creating a TH2 type cytokine bias
07/17/2012US8222210 Methods of using substance P to promote healing of vascular wounds
07/17/2012US8222209 Modified growth hormones that exhibit increased protease resistance and pharmaceutical compositions thereof
07/17/2012US8222208 Methods for characterizing glycoproteins and generating antibodies for same
07/17/2012US8222207 Method of enhancing the mobilization of hematopoietic stem cells using TAT-HOXB4H
07/17/2012US8222206 Method of enhancing the mobilization of hematopoietic stem cells using TAT-HOXB4H
07/17/2012US8222205 Process for solubilizing glucagon-like peptide 1 compounds
07/17/2012US8222204 Influenza inhibiting compositions and methods
07/17/2012US8222203 Macrocyclic oximyl hepatitis C serine protease inhibitors
07/17/2012US8222202 Use of peptidic vasopressin receptor agonists
07/17/2012US8222201 Crystalline form of linaclotide
07/17/2012US8222008 Methods and compositions for treating cancer
07/17/2012US8221805 Compositions for alleviating inflammation and oxidative stress in a mammal
07/17/2012US8221794 Anti-angiogenic nanoparticle compositions
07/17/2012US8221779 Compositions and methods for the delivery of poorly water soluble drugs and methods of treatment
07/17/2012US8221773 Hydrogels and uses thereof
07/17/2012US8221772 1,2-Dipalmitoyl-sn-glycero-3-phosphocholine, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol, palmitic acid or polypeptide comprising lysine or arginine; cysteine or leucine; sodium chloride osmotic agent; aerosol drug delivery; respiratory system disorders; antisecretory and antiinflammatory agents
07/17/2012US8221771 Formulations containing an immune response modifier
07/17/2012US8221767 Antigenicity of infectious pancreatic necrosis virus VP2 sub-viral particles expressed in yeast
07/17/2012US8221765 Multivalent fibronectin based scaffold domain proteins
07/17/2012US8221762 Naturally processed measles virus peptides from class II HLA molecules
07/17/2012US8221759 Neutralizing monoclonal antibodies to respiratory syncytial virus
07/17/2012US8221757 Monoclonal antibodies against extracellular loops of C5aR
07/17/2012US8221748 Compositions and methods for the systemic treatment of arthritis
07/17/2012US8221746 Antioxidant for use in cosmetic, medicated and pharmaceutical preparations
07/17/2012US8221741 Methods for modulating inflammatory and/or immune responses
07/17/2012US8221737 Hepatitis C virus inhibitors
07/17/2012CA2718348C Orally administered peptides to ameliorate atherosclerosis
07/17/2012CA2549550C Botulinum toxin therapy for skin disorders
07/17/2012CA2522561C Quinoxalinyl macrocyclic hepatitis c serine protease inhibitors
07/17/2012CA2505141C Chaperonin 10 immunosuppression
07/17/2012CA2501089C 4-methylhexanoic kahalaide f compound
1 ... 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 ... 3163